{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:02:37Z","timestamp":1784797357451,"version":"3.55.0"},"publisher-location":"Totowa, NJ","reference-count":124,"publisher":"Humana Press","isbn-type":[{"value":"9781617799679","type":"print"},{"value":"9781617799686","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-61779-968-6_34","type":"book-chapter","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T12:50:19Z","timestamp":1346158219000},"page":"533-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation"],"prefix":"10.1007","author":[{"given":"Erwin","family":"De Genst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,12]]},"reference":[{"key":"34_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333\u2013366","journal-title":"Annu Rev Biochem"},{"key":"34_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S1041610295001906","volume":"7","author":"EJ Souetre","year":"1995","unstructured":"Souetre EJ, Qing W, Vigoureux I, Dartigues JF, Lozet H, Lacomblez L, Derouesne C (1995) Economic analysis of Alzheimer\u2019s disease in outpatients: impact of symptom severity. Int Psychogeriatr 7:115\u2013122","journal-title":"Int Psychogeriatr"},{"key":"34_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","volume":"23","author":"PD Sloane","year":"2002","unstructured":"Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S (2002) The public health impact of Alzheimer\u2019s disease, 2000\u20132050: potential implication of treatment advances. Annu Rev Public Health 23:213\u2013231","journal-title":"Annu Rev Public Health"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1532-5415.2002.50065.x","volume":"50","author":"GW Small","year":"2002","unstructured":"Small GW, McDonnell DD, Brooks RL, Papadopoulos G (2002) The impact of \u00adsymptom severity on the cost of Alzheimer\u2019s disease. J Am Geriatr Soc 50:321\u2013327","journal-title":"J Am Geriatr Soc"},{"key":"34_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","volume":"24","author":"CM Dobson","year":"1999","unstructured":"Dobson CM (1999) Protein misfolding, \u00adevolution and disease. Trends Biochem Sci 24:329\u2013332","journal-title":"Trends Biochem Sci"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","volume":"426","author":"CM Dobson","year":"2003","unstructured":"Dobson CM (2003) Protein folding and \u00admisfolding. Nature 426:884\u2013890","journal-title":"Nature"},{"key":"34_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbpa.2008.02.011","volume":"12","author":"LM Luheshi","year":"2008","unstructured":"Luheshi LM, Crowther DC, Dobson CM (2008) Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol 12:25\u201331","journal-title":"Curr Opin Chem Biol"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.febslet.2009.06.030","volume":"583","author":"LM Luheshi","year":"2009","unstructured":"Luheshi LM, Dobson CM (2009) Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 583:2581\u20132586","journal-title":"FEBS Lett"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","volume":"81","author":"M Stefani","year":"2003","unstructured":"Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678\u2013699","journal-title":"J Mol Med"},{"key":"34_CR10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1098\/rsta.2003.1194","volume":"361","author":"M Vendruscolo","year":"2003","unstructured":"Vendruscolo M, Zurdo J, MacPhee CE, Dobson CM (2003) Protein folding and \u00admisfolding: a paradigm of self-assembly and regulation in complex biological systems. Philos Transact A Math Phys Eng Sci 361:1205\u20131222","journal-title":"Philos Transact A Math Phys Eng Sci"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nature04195","volume":"438","author":"CF Wright","year":"2005","unstructured":"Wright CF, Teichmann SA, Clarke J, Dobson CM (2005) The importance of sequence diversity in the aggregation and evolution of proteins. Nature 438:878\u2013881","journal-title":"Nature"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/iub.117","volume":"60","author":"H Ecroyd","year":"2008","unstructured":"Ecroyd H, Carver JA (2008) Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60:769\u2013774","journal-title":"IUBMB Life"},{"key":"34_CR13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1178250","volume":"326","author":"TP Knowles","year":"2009","unstructured":"Knowles TP, Waudby CA, Devlin GL, Cohen SI, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326:1533\u20131537","journal-title":"Science"},{"key":"34_CR14","first-page":"1","volume":"68","author":"CM Dobson","year":"2001","unstructured":"Dobson CM (2001) Protein folding and its links with human disease. Biochem Soc Symp 68:1\u201326","journal-title":"Biochem Soc Symp"},{"key":"34_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35065514","volume":"410","author":"M Fandrich","year":"2001","unstructured":"Fandrich M, Fletcher MA, Dobson CM (2001) Amyloid fibrils from muscle myoglobin. Nature 410:165\u2013166","journal-title":"Nature"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"31374","DOI":"10.1074\/jbc.M400348200","volume":"279","author":"M Bucciantini","year":"2004","unstructured":"Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM, Stefani M (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279:31374\u201331382","journal-title":"J Biol Chem"},{"key":"34_CR17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biochi.2004.09.012","volume":"86","author":"M Dumoulin","year":"2004","unstructured":"Dumoulin M, Dobson CM (2004) Probing the origins, diagnosis and treatment of amyloid diseases using antibodies. Biochimie 86:589\u2013600","journal-title":"Biochimie"},{"key":"34_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0167-5699(00)01683-2","volume":"21","author":"CA Borrebaeck","year":"2000","unstructured":"Borrebaeck CA (2000) Antibodies in diagnostics\u2014from immunoassays to protein chips. Immunol Today 21:379\u2013382","journal-title":"Immunol Today"},{"key":"34_CR19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nm0103-129","volume":"9","author":"PJ Hudson","year":"2003","unstructured":"Hudson PJ, Souriau C (2003) Engineered antibodies. Nat Med 9:129\u2013134","journal-title":"Nat Med"},{"key":"34_CR20","first-page":"197","volume":"6","author":"RP Valle","year":"2003","unstructured":"Valle RP, Jendoubi M (2003) Antibody-based technologies for target discovery. Curr Opin Drug Discov Devel 6:197\u2013203","journal-title":"Curr Opin Drug Discov Devel"},{"key":"34_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09648","volume":"469","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, Schnapp A, Konetzki I, Sunahara RK, Gellman SH, Pautsch A, Steyaert J, Weis WI, Kobilka BK (2011) Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469:175\u2013180","journal-title":"Nature"},{"issue":"7405","key":"34_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11155","volume":"487","author":"E Baranova","year":"2012","unstructured":"Baranova E, Fronzes R, Garcia-Pino A, Van Gerven N, Papapostolou D, Pehau-Arnaudet G, Pardon E, Steyaert J, Howorka S, Remaut H (2012) SbsB structure and lattice reconstruction unveil Ca(2+) triggered S-layer assembly. Nature 487(7405):119\u2013122","journal-title":"Nature"},{"key":"34_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","volume":"26","author":"S Muyldermans","year":"2001","unstructured":"Muyldermans S, Cambillau C, Wyns L (2001) Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem Sci 26:230\u2013235","journal-title":"Trends Biochem Sci"},{"key":"34_CR24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/erm.10.62","volume":"10","author":"L Huang","year":"2010","unstructured":"Huang L, Muyldermans S, Saerens D (2010) Nanobodies(R): proficient tools in diagnostics. Expert Rev Mol Diagn 10:777\u2013785","journal-title":"Expert Rev Mol Diagn"},{"key":"34_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14712598.5.1.111","volume":"5","author":"H Revets","year":"2005","unstructured":"Revets H, De Baetselier P, Muyldermans S (2005) Nanobodies as novel agents for cancer therapy. Expert Opin Biol Ther 5:111\u2013124","journal-title":"Expert Opin Biol Ther"},{"key":"34_CR26","first-page":"277","volume":"74","author":"S Muyldermans","year":"2001","unstructured":"Muyldermans S (2001) Single domain camel antibodies: current status. J Biotechnol 74:277\u2013302","journal-title":"J Biotechnol"},{"key":"34_CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","volume":"7","author":"S Muyldermans","year":"1994","unstructured":"Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R (1994) Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng 7:1129\u20131135","journal-title":"Protein Eng"},{"key":"34_CR28","doi-asserted-by":"crossref","first-page":"e9804","DOI":"10.1371\/journal.pone.0009804","volume":"5","author":"DR Jones","year":"2010","unstructured":"Jones DR, Taylor WA, Bate C, David M, Tayebi M (2010) A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines. PLoS One 5:e9804","journal-title":"PLoS One"},{"key":"34_CR29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jmb.2010.07.001","volume":"402","author":"EJ De Genst","year":"2010","unstructured":"De Genst EJ, Guilliams T, Wellens J, O\u2019Day EM, Waudby CA, Meehan S, Dumoulin M, Hsu ST, Cremades N, Verschueren KH, Pardon E, Wyns L, Steyaert J, Christodoulou J, Dobson CM (2010) Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. J Mol Biol 402:326\u2013343","journal-title":"J Mol Biol"},{"key":"34_CR30","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1073\/pnas.0703793104","volume":"104","author":"G Habicht","year":"2007","unstructured":"Habicht G, Haupt C, Friedrich RP, Hortschansky P, Sachse C, Meinhardt J, Wieligmann K, Gellermann GP, Brodhun M, Gotz J, Halbhuber KJ, Rocken C, Horn U, Fandrich M (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci U S A 104:19232\u201319237","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR31","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1021\/bi8005797","volume":"47","author":"PH Chan","year":"2008","unstructured":"Chan PH, Pardon E, Menzer L, De Genst E, Kumita JR, Christodoulou J, Saerens D, Brans A, Bouillenne F, Archer DB, Robinson CV, Muyldermans S, Matagne A, Redfield C, Wyns L, Dobson CM, Dumoulin M (2008) Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. Biochemistry 47:11041\u201311054","journal-title":"Biochemistry"},{"key":"34_CR32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jmb.2004.11.020","volume":"346","author":"M Dumoulin","year":"2005","unstructured":"Dumoulin M, Canet D, Last AM, Pardon E, Archer DB, Muyldermans S, Wyns L, Matagne A, Robinson CV, Redfield C, Dobson CM (2005) Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J Mol Biol 346:773\u2013788","journal-title":"J Mol Biol"},{"key":"34_CR33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature01870","volume":"424","author":"M Dumoulin","year":"2003","unstructured":"Dumoulin M, Last AM, Desmyter A, Decanniere K, Canet D, Larsson G, Spencer A, Archer DB, Sasse J, Muyldermans S, Wyns L, Redfield C, Matagne A, Robinson CV, Dobson CM (2003) A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424:783\u2013788","journal-title":"Nature"},{"key":"34_CR34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molimm.2008.09.008","volume":"46","author":"P Lafaye","year":"2009","unstructured":"Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F (2009) Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation. Mol Immunol 46:695\u2013704","journal-title":"Mol Immunol"},{"key":"34_CR35","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1073\/pnas.1008560108","volume":"108","author":"K Domanska","year":"2011","unstructured":"Domanska K, Vanderhaegen S, Srinivasan V, Pardon E, Dupeux F, Marquez JA, Giorgetti S, Stoppini M, Wyns L, Bellotti V, Steyaert J (2011) Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant. Proc Natl Acad Sci U S A 108:1314\u20131319","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR36","doi-asserted-by":"crossref","first-page":"36724","DOI":"10.1074\/jbc.M806766200","volume":"283","author":"H Taguchi","year":"2008","unstructured":"Taguchi H, Planque S, Sapparapu G, Boivin S, Hara M, Nishiyama Y, Paul S (2008) Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds. J Biol Chem 283:36724\u201336733","journal-title":"J Biol Chem"},{"key":"34_CR37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmb.2004.07.054","volume":"342","author":"DW Colby","year":"2004","unstructured":"Colby DW, Garg P, Holden T, Chao G, Webster JM, Messer A, Ingram VM, Wittrup KD (2004) Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. J Mol Biol 342:901\u2013912","journal-title":"J Mol Biol"},{"key":"34_CR38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jmb.2011.09.034","volume":"414","author":"A Schiefner","year":"2011","unstructured":"Schiefner A, Chatwell L, Korner J, Neumaier I, Colby DW, Volkmer R, Wittrup KD, Skerra A (2011) A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition. J Mol Biol 414:337\u2013355","journal-title":"J Mol Biol"},{"key":"34_CR39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.wco.0000186841.43505.e6","volume":"18","author":"MR Cookson","year":"2005","unstructured":"Cookson MR, Xiromerisiou G, Singleton A (2005) How genetics research in Parkinson\u2019s disease is enhancing understanding of the common idiopathic forms of the disease. Curr Opin Neurol 18:706\u2013711","journal-title":"Curr Opin Neurol"},{"key":"34_CR40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"34_CR41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507\u2013511","journal-title":"Nature"},{"key":"34_CR42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1515\/CCLM.2002.219","volume":"40","author":"A Olofsson","year":"2002","unstructured":"Olofsson A, Ostman J, Lundgren E (2002) Amyloid: morphology and toxicity. Clin Chem Lab Med 40:1266\u20131270","journal-title":"Clin Chem Lab Med"},{"key":"34_CR43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA, Bertoncini CW, Wood NW, Knowles TP, Dobson CM, Klenerman D (2012) Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell 149:1048\u20131059","journal-title":"Cell"},{"key":"34_CR44","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jmb.2007.02.089","volume":"368","author":"S Emadi","year":"2007","unstructured":"Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR (2007) Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. J Mol Biol 368:1132\u20131144","journal-title":"J Mol Biol"},{"key":"34_CR45","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1074\/jbc.M806559200","volume":"284","author":"S Emadi","year":"2009","unstructured":"Emadi S, Kasturirangan S, Wang MS, Schulz P, Sierks MR (2009) Detecting morphologically distinct oligomeric forms of alpha-\u00adsynuclein. J Biol Chem 284:11048\u201311058","journal-title":"J Biol Chem"},{"key":"34_CR46","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/bi036281f","volume":"43","author":"S Emadi","year":"2004","unstructured":"Emadi S, Liu R, Yuan B, Schulz P, McAllister C, Lyubchenko Y, Messer A, Sierks MR (2004) Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry 43:2871\u20132878","journal-title":"Biochemistry"},{"key":"34_CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","volume":"377","author":"SM Lynch","year":"2008","unstructured":"Lynch SM, Zhou C, Messer A (2008) An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J Mol Biol 377:136\u2013147","journal-title":"J Mol Biol"},{"key":"34_CR48","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ymthe.2004.08.019","volume":"10","author":"C Zhou","year":"2004","unstructured":"Zhou C, Emadi S, Sierks MR, Messer A (2004) A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Mol Ther 10:1023\u20131031","journal-title":"Mol Ther"},{"key":"34_CR49","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1021\/ja0582206","volume":"128","author":"W Bermel","year":"2006","unstructured":"Bermel W, Bertini I, Felli IC, Lee YM, Luchinat C, Pierattelli R (2006) Protonless NMR experiments for sequence-specific assignment of backbone nuclei in unfolded proteins. J Am Chem Soc 128:3918\u20133919","journal-title":"J Am Chem Soc"},{"key":"34_CR50","doi-asserted-by":"crossref","first-page":"24774","DOI":"10.1074\/jbc.M100770200","volume":"276","author":"J Tanha","year":"2001","unstructured":"Tanha J, Xu P, Chen Z, Ni F, Kaplan H, Narang SA, MacKenzie CR (2001) Optimal design features of camelized human single-domain antibody libraries. J Biol Chem 276:24774\u201324780","journal-title":"J Biol Chem"},{"key":"34_CR51","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1021\/bi012169a","volume":"41","author":"W Vranken","year":"2002","unstructured":"Vranken W, Tolkatchev D, Xu P, Tanha J, Chen Z, Narang S, Ni F (2002) Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH\/VL interface. Biochemistry 41:8570\u20138579","journal-title":"Biochemistry"},{"key":"34_CR52","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","volume":"105","author":"M Vilar","year":"2008","unstructured":"Vilar M, Chou HT, Luhrs T, Maji SK, Riek-Loher D, Verel R, Manning G, Stahlberg H, Riek R (2008) The fold of alpha-synuclein fibrils. Proc Natl Acad Sci U S A 105:8637\u20138642","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"34_CR54","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"I Kuperstein","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van Der Werf K, Subramaniam V, Braeken D, Callewaert G, Bartic C, D\u2019Hooge R, Martins IC, Rousseau F, Schymkowitz J, De Strooper B (2010) Neurotoxicity of Alzheimer\u2019s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J 29:3408\u20133420","journal-title":"EMBO J"},{"key":"34_CR55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9:768\u2013778","journal-title":"Nat Rev Neurosci"},{"key":"34_CR56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120:545\u2013555","journal-title":"Cell"},{"key":"34_CR57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, Gotz J (2011) Amyloid-beta and tau\u2014a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12:65\u201372","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"34_CR58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/156720511796391872","volume":"8","author":"FF Diana","year":"2011","unstructured":"Diana FF, Silva Esteves AR, Oliveira CR, Cardoso SM (2011) Mitochondria: the common upstream driver of abeta and tau pathology in Alzheimer s disease. Curr Alzheimer Res 8(5):563\u2013572","journal-title":"Curr Alzheimer Res"},{"key":"34_CR59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1042\/BST0380993","volume":"38","author":"FM LaFerla","year":"2010","unstructured":"LaFerla FM (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38:993\u2013995","journal-title":"Biochem Soc Trans"},{"key":"34_CR60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-010-0691-0","volume":"121","author":"L Reiniger","year":"2011","unstructured":"Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S (2011) Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol 121:5\u201320","journal-title":"Acta Neuropathol"},{"key":"34_CR61","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis. Neuron 60:534\u2013542","journal-title":"Neuron"},{"key":"34_CR62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones M, Laferla FM (2006) Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 3:437\u2013448","journal-title":"Curr Alzheimer Res"},{"key":"34_CR63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11:170\u2013176","journal-title":"Trends Mol Med"},{"key":"34_CR64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuron.2004.07.023","volume":"43","author":"M Hutton","year":"2004","unstructured":"Hutton M, McGowan E (2004) Clearing tau pathology with Abeta immunotherapy\u2014reversible and irreversible stages revealed. Neuron 43:293\u2013294","journal-title":"Neuron"},{"key":"34_CR65","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/jnr.22516","volume":"88","author":"Y Seino","year":"2010","unstructured":"Seino Y, Kawarabayashi T, Wakasaya Y, Watanabe M, Takamura A, Yamamoto-Watanabe Y, Kurata T, Abe K, Ikeda M, Westaway D, Murakami T, Hyslop PS, Matsubara E, Shoji M (2010) Amyloid beta accelerates phosphorylation of tau and \u00adneurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model. J Neurosci Res 88:3547\u20133554","journal-title":"J Neurosci Res"},{"key":"34_CR66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.crvi.2004.10.013","volume":"328","author":"PH St George-Hyslop","year":"2005","unstructured":"St George-Hyslop PH, Petit A (2005) Molecular biology and genetics of Alzheimer\u2019s disease. C R Biol 328:119\u2013130","journal-title":"C R Biol"},{"key":"34_CR67","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"34_CR68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmb.2006.07.011","volume":"362","author":"C Sachse","year":"2006","unstructured":"Sachse C, Xu C, Wieligmann K, Diekmann S, Grigorieff N, Fandrich M (2006) Quaternary structure of a mature amyloid fibril from Alzheimer\u2019s Abeta(1\u201340) peptide. J Mol Biol 362:347\u2013354","journal-title":"J Mol Biol"},{"key":"34_CR69","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/bi0492354","volume":"43","author":"R Liu","year":"2004","unstructured":"Liu R, McAllister C, Lyubchenko Y, Sierks MR (2004) Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity. Biochemistry 43:9999\u201310007","journal-title":"Biochemistry"},{"key":"34_CR70","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1074\/jbc.M707983200","volume":"283","author":"H Taguchi","year":"2008","unstructured":"Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P, Friedland RP, Ramsland PA, Edmundson AB, Weksler ME, Paul S (2008) Autoantibody-catalyzed hydrolysis of amyloid beta peptide. J Biol Chem 283:4714\u20134722","journal-title":"J Biol Chem"},{"key":"34_CR71","first-page":"9","volume":"75","author":"EM Prager","year":"1996","unstructured":"Prager EM, Jolles P (1996) Animal lysozymes c and g: an overview. EXS 75:9\u201331","journal-title":"EXS"},{"key":"34_CR72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","volume":"385","author":"DR Booth","year":"1997","unstructured":"Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CC, Pepys MB (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385:787\u2013793","journal-title":"Nature"},{"key":"34_CR73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/362553a0","volume":"362","author":"MB Pepys","year":"1993","unstructured":"Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ et al (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362:553\u2013557","journal-title":"Nature"},{"key":"34_CR74","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsb0996-803","volume":"3","author":"A Desmyter","year":"1996","unstructured":"Desmyter A, Transue TR, Ghahroudi MA, Thi MH, Poortmans F, Hamers R, Muyldermans S, Wyns L (1996) Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol 3:803\u2013811","journal-title":"Nat Struct Biol"},{"key":"34_CR75","first-page":"9","volume":"72","author":"J Floege","year":"1996","unstructured":"Floege J, Ehlerding G (1996) Beta-2-microglobulin-associated amyloidosis. Nephron 72:9\u201326","journal-title":"Nephron"},{"key":"34_CR76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/342692a0","volume":"342","author":"TP Garrett","year":"1989","unstructured":"Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692\u2013696","journal-title":"Nature"},{"key":"34_CR77","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-2836(03)00688-0","volume":"330","author":"S Jones","year":"2003","unstructured":"Jones S, Smith DP, Radford SE (2003) Role of the N and C-terminal strands of beta 2-microglobulin in amyloid formation at \u00adneutral pH. J Mol Biol 330:935\u2013941","journal-title":"J Mol Biol"},{"key":"34_CR78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nsmb1058","volume":"13","author":"TR Jahn","year":"2006","unstructured":"Jahn TR, Parker MJ, Homans SW, Radford SE (2006) Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 13:195\u2013201","journal-title":"Nat Struct Mol Biol"},{"key":"34_CR79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbapap.2005.07.006","volume":"1753","author":"SE Radford","year":"2005","unstructured":"Radford SE, Gosal WS, Platt GW (2005) Towards an understanding of the structural molecular mechanism of beta(2)-microglobulin amyloid formation in vitro. Biochim Biophys Acta 1753:51\u201363","journal-title":"Biochim Biophys Acta"},{"key":"34_CR80","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.bpj.2012.02.045","volume":"102","author":"D Ami","year":"2012","unstructured":"Ami D, Ricagno S, Bolognesi M, Bellotti V, Doglia SM, Natalello A (2012) Structure, stability, and aggregation of beta-2 microglobulin mutants: insights from a Fourier transform infrared study in solution and in the crystalline state. Biophys J 102:1676\u20131684","journal-title":"Biophys J"},{"key":"34_CR81","doi-asserted-by":"crossref","unstructured":"Colombo M, de Rosa M, Bellotti V, Ricagno S, Bolognesi M (2012) A recurrent D-strand association interface is observed in beta-2 microglobulin oligomers. FEBS J","DOI":"10.1111\/j.1742-4658.2012.08510.x"},{"key":"34_CR82","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1742-4658.2011.08157.x","volume":"278","author":"S Azinas","year":"2011","unstructured":"Azinas S, Colombo M, Barbiroli A, Santambrogio C, Giorgetti S, Raimondi S, Bonomi F, Grandori R, Bellotti V, Ricagno S, Bolognesi M (2011) D-strand perturbation and amyloid propensity in beta-2 microglobulin. FEBS J 278:2349\u20132358","journal-title":"FEBS J"},{"key":"34_CR83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jb\/mvr034","volume":"150","author":"M Colombo","year":"2011","unstructured":"Colombo M, Ricagno S, Barbiroli A, Santambrogio C, Giorgetti S, Raimondi S, Bonomi F, Grandori R, Bellotti V, Bolognesi M (2011) The effects of an ideal beta-turn on beta-2 microglobulin fold stability. J Biochem 150:39\u201347","journal-title":"J Biochem"},{"key":"34_CR84","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/prot.22940","volume":"79","author":"F Fogolari","year":"2011","unstructured":"Fogolari F, Corazza A, Varini N, Rotter M, Gumral D, Codutti L, Rennella E, Viglino P, Bellotti V, Esposito G (2011) Molecular dynamics simulation of beta(2)-microglobulin in denaturing and stabilizing conditions. Proteins 79:986\u20131001","journal-title":"Proteins"},{"key":"34_CR85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.sbi.2009.04.008","volume":"19","author":"S Koide","year":"2009","unstructured":"Koide S (2009) Engineering of recombinant crystallization chaperones. Curr Opin Struct Biol 19:449\u2013457","journal-title":"Curr Opin Struct Biol"},{"issue":"9","key":"34_CR86","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/protein\/gzr017","volume":"24","author":"RN Abskharon","year":"2011","unstructured":"Abskharon RN, Soror SH, Pardon E, El Hassan H, Legname G, Steyaert J, Wohlkonig A (2011) Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrPc-nanobody complexes. Protein Eng Des Sel 24(9):737\u2013741","journal-title":"Protein Eng Des Sel"},{"key":"34_CR87","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 1804:1405\u20131412","journal-title":"Biochim Biophys Acta"},{"key":"34_CR88","doi-asserted-by":"crossref","first-page":"16462","DOI":"10.1074\/jbc.C300049200","volume":"278","author":"T Ban","year":"2003","unstructured":"Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y (2003) Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem 278:16462\u201316465","journal-title":"J Biol Chem"},{"key":"34_CR89","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","volume":"309","author":"H LeVine III","year":"1999","unstructured":"LeVine H III (1999) Quantification of \u00adbeta-sheet amyloid fibril structures with \u00adthioflavin T. Methods Enzymol 309:274\u2013284","journal-title":"Methods Enzymol"},{"key":"34_CR90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ajcp\/44.1.59","volume":"44","author":"DR Rogers","year":"1965","unstructured":"Rogers DR (1965) Screening for amyloid with the thioflavin-T fluorescent method. Am J Clin Pathol 44:59\u201361","journal-title":"Am J Clin Pathol"},{"key":"34_CR91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0076-6879(99)09021-7","volume":"309","author":"WE Klunk","year":"1999","unstructured":"Klunk WE, Jacob RF, Mason RP (1999) Quantifying amyloid by congo red spectral shift assay. Methods Enzymol 309:285\u2013305","journal-title":"Methods Enzymol"},{"key":"34_CR92","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0022-2836(92)90532-O","volume":"227","author":"WG Turnell","year":"1992","unstructured":"Turnell WG, Finch JT (1992) Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J Mol Biol 227:1205\u20131223","journal-title":"J Mol Biol"},{"key":"34_CR93","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.66.4.1044","volume":"66","author":"EP Benditt","year":"1970","unstructured":"Benditt EP, Eriksen N, Berglund C (1970) Congo red dichroism with dispersed amyloid fibrils, an extrinsic cotton effect. Proc Natl Acad Sci U S A 66:1044\u20131051","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2010.09.018","volume":"173","author":"C Goldsbury","year":"2011","unstructured":"Goldsbury C, Baxa U, Simon MN, Steven AC, Engel A, Wall JS, Aebi U, Muller SA (2011) Amyloid structure and assembly: insights from scanning transmission electron microscopy. J Struct Biol 173:1\u201313","journal-title":"J Struct Biol"},{"key":"34_CR95","doi-asserted-by":"crossref","first-page":"14339","DOI":"10.1073\/pnas.0907821106","volume":"106","author":"B Chen","year":"2009","unstructured":"Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R (2009) Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci U S A 106:14339\u201314344","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR96","first-page":"349","volume":"242","author":"J Legleiter","year":"2004","unstructured":"Legleiter J, Kowalewski T (2004) Atomic force microscopy of beta-amyloid: static and dynamic studies of nanostructure and its formation. Methods Mol Biol 242:349\u2013364","journal-title":"Methods Mol Biol"},{"key":"34_CR97","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0076-6879(99)09035-7","volume":"309","author":"TT Ding","year":"1999","unstructured":"Ding TT, Harper JD (1999) Analysis of amyloid-beta assemblies using tapping mode atomic force microscopy under ambient conditions. Methods Enzymol 309:510\u2013525","journal-title":"Methods Enzymol"},{"key":"34_CR98","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1073\/pnas.96.7.3688","volume":"96","author":"T Kowalewski","year":"1999","unstructured":"Kowalewski T, Holtzman DM (1999) In situ atomic force microscopy study of Alzheimer\u2019s beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A 96:3688\u20133693","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/jmbi.1998.2299","volume":"285","author":"C Goldsbury","year":"1999","unstructured":"Goldsbury C, Kistler J, Aebi U, Arvinte T, Cooper GJ (1999) Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol 285:33\u201339","journal-title":"J Mol Biol"},{"key":"34_CR100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0076-6879(99)09036-9","volume":"309","author":"LC Serpell","year":"1999","unstructured":"Serpell LC, Fraser PE, Sunde M (1999) X-ray fiber diffraction of amyloid fibrils. Methods Enzymol 309:526\u2013536","journal-title":"Methods Enzymol"},{"key":"34_CR101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.131","volume":"5","author":"F Chiti","year":"2009","unstructured":"Chiti F, Dobson CM (2009) Amyloid formation by globular proteins under native conditions. Nat Chem Biol 5:15\u201322","journal-title":"Nat Chem Biol"},{"key":"34_CR102","doi-asserted-by":"crossref","first-page":"031001","DOI":"10.1088\/1478-3975\/7\/3\/031001","volume":"7","author":"J Hohlbein","year":"2010","unstructured":"Hohlbein J, Gryte K, Heilemann M, Kapanidis AN (2010) Surfing on a new wave of single-molecule fluorescence methods. Phys Biol 7:031001","journal-title":"Phys Biol"},{"key":"34_CR103","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2010.04.070","volume":"396","author":"R Rigler","year":"2010","unstructured":"Rigler R (2010) Fluorescence and single \u00admolecule analysis in cell biology. Biochem Biophys Res Commun 396:170\u2013175","journal-title":"Biochem Biophys Res Commun"},{"key":"34_CR104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.biochem.77.070606.101543","volume":"77","author":"C Joo","year":"2008","unstructured":"Joo C, Balci H, Ishitsuka Y, Buranachai C, Ha T (2008) Advances in single-molecule fluorescence methods for molecular biology. Annu Rev Biochem 77:51\u201376","journal-title":"Annu Rev Biochem"},{"key":"34_CR105","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1021\/cr0404343","volume":"106","author":"X Michalet","year":"2006","unstructured":"Michalet X, Weiss S, Jager M (2006) Single-molecule fluorescence studies of protein folding and conformational dynamics. Chem Rev 106:1785\u20131813","journal-title":"Chem Rev"},{"key":"34_CR106","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1073\/pnas.0803086105","volume":"105","author":"A Orte","year":"2008","unstructured":"Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM, Klenerman D (2008) Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A 105:14424\u201314429","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nsmb.2191","volume":"19","author":"P Narayan","year":"2012","unstructured":"Narayan P, Orte A, Clarke RW, Bolognesi B, Hook S, Ganzinger KA, Meehan S, Wilson MR, Dobson CM, Klenerman D (2012) The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1\u201340) peptide. Nat Struct Mol Biol 19:79\u201383","journal-title":"Nat Struct Mol Biol"},{"key":"34_CR108","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.coph.2010.09.013","volume":"10","author":"CM Yengo","year":"2010","unstructured":"Yengo CM, Berger CL (2010) Fluorescence anisotropy and resonance energy transfer: powerful tools for measuring real time protein dynamics in a physiological environment. Curr Opin Pharmacol 10:731\u2013737","journal-title":"Curr Opin Pharmacol"},{"key":"34_CR109","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/meth.2001.1189","volume":"24","author":"AK Kenworthy","year":"2001","unstructured":"Kenworthy AK (2001) Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24:289\u2013296","journal-title":"Methods"},{"key":"34_CR110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/1011-1344(92)85039-W","volume":"12","author":"L Matyus","year":"1992","unstructured":"Matyus L (1992) Fluorescence resonance energy transfer measurements on cell surfaces. A spectroscopic tool for determining protein interactions. J Photochem Photobiol B 12:323\u2013337","journal-title":"J Photochem Photobiol B"},{"key":"34_CR111","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/78948","volume":"7","author":"PR Selvin","year":"2000","unstructured":"Selvin PR (2000) The renaissance of fluorescence resonance energy transfer. Nat Struct Biol 7:730\u2013734","journal-title":"Nat Struct Biol"},{"key":"34_CR112","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1073\/pnas.97.10.5468","volume":"97","author":"J Bieschke","year":"2000","unstructured":"Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci 97:5468\u20135473","journal-title":"Proc Natl Acad Sci"},{"key":"34_CR113","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00253-008-1447-9","volume":"79","author":"M Cao","year":"2008","unstructured":"Cao M, Cao P, Yan H, Ren F, Lu W, Hu Y, Zhang S (2008) Construction and characterization of an enhanced GFP-tagged anti-BAFF scFv antibody. Appl Microbiol Biotechnol 79:423\u2013431","journal-title":"Appl Microbiol Biotechnol"},{"key":"34_CR114","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2007.11.141","volume":"366","author":"P Didier","year":"2008","unstructured":"Didier P, Weiss E, Sibler AP, Philibert P, Martineau P, Bigot JY, Guidoni L (2008) Femtosecond spectroscopy probes the folding quality of antibody fragments expressed as GFP fusions in the cytoplasm. Biochem Biophys Res Commun 366:878\u2013884","journal-title":"Biochem Biophys Res Commun"},{"key":"34_CR115","first-page":"265","volume":"183","author":"A Schots","year":"2002","unstructured":"Schots A, van der Wolf JM (2002) Green fluorescent protein fluobody immunosensors. Immunofluorescence with GFP-antibody fusion proteins. Methods Mol Biol 183:265\u2013273","journal-title":"Methods Mol Biol"},{"key":"34_CR116","doi-asserted-by":"crossref","first-page":"17616","DOI":"10.1073\/pnas.0408134101","volume":"101","author":"DW Colby","year":"2004","unstructured":"Colby DW, Chu Y, Cassady JP, Duennwald M, Zazulak H, Webster JM, Messer A, Lindquist S, Ingram VM, Wittrup KD (2004) Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proc Natl Acad Sci U S A 101:17616\u201317621","journal-title":"Proc Natl Acad Sci U S A"},{"key":"34_CR117","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00063030-200620060-00002","volume":"20","author":"A Messer","year":"2006","unstructured":"Messer A, McLear J (2006) The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseases. BioDrugs 20:327\u2013333","journal-title":"BioDrugs"},{"key":"34_CR118","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2005.04.003","volume":"12","author":"TW Miller","year":"2005","unstructured":"Miller TW, Messer A (2005) Intrabody \u00adapplications in neurological disorders: progress and future prospects. Mol Ther 12:394\u2013401","journal-title":"Mol Ther"},{"key":"34_CR119","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156652408783565595","volume":"8","author":"A Cardinale","year":"2008","unstructured":"Cardinale A, Biocca S (2008) Combating protein misfolding and aggregation by intracellular antibodies. Curr Mol Med 8:2\u201311","journal-title":"Curr Mol Med"},{"key":"34_CR120","doi-asserted-by":"crossref","first-page":"e29199","DOI":"10.1371\/journal.pone.0029199","volume":"6","author":"DC Butler","year":"2011","unstructured":"Butler DC, Messer A (2011) Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLoS One 6:e29199","journal-title":"PLoS One"},{"key":"34_CR121","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pneurobio.2011.11.004","volume":"97","author":"DC Butler","year":"2012","unstructured":"Butler DC, McLear JA, Messer A (2012) Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Prog Neurobiol 97:190\u2013204","journal-title":"Prog Neurobiol"},{"key":"34_CR122","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1471-4159.2005.03463.x","volume":"95","author":"A Abulrob","year":"2005","unstructured":"Abulrob A, Sprong H, Van Bergen en Henegouwen P, Stanimirovic D (2005) The blood\u2013brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem 95:1201\u20131214","journal-title":"J Neurochem"},{"key":"34_CR123","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1358\/dnp.2008.21.9.1290820","volume":"21","author":"RJ Boado","year":"2008","unstructured":"Boado RJ (2008) A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery. Drug News Perspect 21:489\u2013503","journal-title":"Drug News Perspect"},{"key":"34_CR124","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1096\/fj.01-0343fje","volume":"16","author":"A Muruganandam","year":"2002","unstructured":"Muruganandam A, Tanha J, Narang S, Stanimirovic D (2002) Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood\u2013brain barrier endothelium. FASEB J 16:240\u2013242","journal-title":"FASEB J"}],"container-title":["Methods in Molecular Biology","Single Domain Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-968-6_34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:24:25Z","timestamp":1784795065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-61779-968-6_34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781617799679","9781617799686"],"references-count":124,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-968-6_34","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"12 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}